Advertisement
| covid vaccine studies 2023: CDC Yellow Book 2018: Health Information for International Travel Centers for Disease Control and Prevention CDC, 2017-04-17 THE ESSENTIAL WORK IN TRAVEL MEDICINE -- NOW COMPLETELY UPDATED FOR 2018 As unprecedented numbers of travelers cross international borders each day, the need for up-to-date, practical information about the health challenges posed by travel has never been greater. For both international travelers and the health professionals who care for them, the CDC Yellow Book 2018: Health Information for International Travel is the definitive guide to staying safe and healthy anywhere in the world. The fully revised and updated 2018 edition codifies the U.S. government's most current health guidelines and information for international travelers, including pretravel vaccine recommendations, destination-specific health advice, and easy-to-reference maps, tables, and charts. The 2018 Yellow Book also addresses the needs of specific types of travelers, with dedicated sections on: · Precautions for pregnant travelers, immunocompromised travelers, and travelers with disabilities · Special considerations for newly arrived adoptees, immigrants, and refugees · Practical tips for last-minute or resource-limited travelers · Advice for air crews, humanitarian workers, missionaries, and others who provide care and support overseas Authored by a team of the world's most esteemed travel medicine experts, the Yellow Book is an essential resource for travelers -- and the clinicians overseeing their care -- at home and abroad. |
| covid vaccine studies 2023: Maternal Immunization Elke Leuridan, Marta Nunes, Chrissie Jones, 2019-11-26 Immunization during pregnancy with currently recommended vaccines prevents infection in the mother, the unborn fetus, and the young infant, and there is an increasing focus from different stakeholders to use this approach for other infections of importance to protect these vulnerable groups. The aim of this Maternal Immunization book is to provide a contemporary overview of vaccines used in pregnancy (and the lactation period), with emphasis on aspects of importance for the target groups, namely, rationale for the use of vaccines in pregnancy, safety, immunogenicity (immunology), timing to vaccinate, repeat doses, protective effects in the mother, fetus, and infant, and public acceptance and implementation, of existing and of future vaccines. - Provides an overview of a quickly evolving topic. This will benefit the reader who wishes to rapidly become informed and up-to-date with new developments in this field - Suitable to a broad audience: scientific researchers, obstetricians, gynecologists, neonatologists, vaccinators, pediatricians, students, and industry. Maternal vaccination impacts a wide range of specialists - Allows health care professionals/researchers to gain insight into other aspects of vaccination in pregnancy outside of their specialism - Is coauthored by specialists from multiple disciplines, providing a diverse view of the subject, increasing its interest and appeal - Creates awareness of the current developments in this area of medicine and of the potential of maternal vaccination to improve the health of mothers and infants worldwide |
| covid vaccine studies 2023: The Ethics of Pandemics Meredith Celene Schwartz, 2020-07-30 A portion of the revenue from this book’s sales will be donated to Doctors Without Borders to assist in the fight against COVID-19. The rapid spread of COVID-19 has had an unprecedented impact on modern health-care systems and has given rise to a number of complex ethical issues. This collection of readings and case studies offers an overview of some of the most pressing of these issues, such as the allocation of ventilators and other scarce resources, the curtailing of standard privacy measures for the sake of public health, and the potential obligations of health-care professionals to continue operating in dangerous work environments. |
| covid vaccine studies 2023: Modernizing Global Health Security to Prevent, Detect, and Respond Scott J.N. McNabb, Affan T. Shaikh, Carol J. Haley, 2023-02-15 Modernizing Global Health Security to Prevent, Detect, and Respond explores the history of public health surveillance, current governance and legal structures. The book explores global public health and the challenges in preventing, detecting and responding to emerging threats. It describes a vision for the future of global public health, with an aim of charting a way forward that includes an understanding that epidemics are expected, but pandemics are preventable. Major topics covered include global health security, epidemic/pandemic prevention, detection and response, One Health and zoonosis, virus outbreaks of Ebola, Zika, MERS-CoV and COVID-19, manmade public health threats and environmental health, and more. This book provides the context researchers, practitioners and graduate-level students need in public health to better understand what was, what is and what could be for global health security. Highlights emerging threats to public health (e.g., disease, climate change, antibiotic resistance, PFAS) Discusses new approaches to global health security Leverages technological innovations to advance public health Includes practical examples and case studies from around the world |
| covid vaccine studies 2023: Epidemiology and Prevention of Vaccine-Preventable Diseases, 13th Edition E-Book Jennifer Hamborsky, MPH, MCHES, Andrew Kroger, MD, MPH, Charles (Skip) Wolfe, 2015-10-19 The Public Health Foundation (PHF) in partnership with the Centers for Disease Control and Prevention (CDC) is pleased to announce the availability of Epidemiology and Prevention of Vaccine-Preventable Diseases, 13th Edition or “The Pink Book” E-Book. This resource provides the most current, comprehensive, and credible information on vaccine-preventable diseases, and contains updated content on immunization and vaccine information for public health practitioners, healthcare providers, health educators, pharmacists, nurses, and others involved in administering vaccines. “The Pink Book E-Book” allows you, your staff, and others to have quick access to features such as keyword search and chapter links. Online schedules and sources can also be accessed directly through e-readers with internet access. Current, credible, and comprehensive, “The Pink Book E-Book” contains information on each vaccine-preventable disease and delivers immunization providers with the latest information on: Principles of vaccination General recommendations on immunization Vaccine safety Child/adult immunization schedules International vaccines/Foreign language terms Vaccination data and statistics The E-Book format contains all of the information and updates that are in the print version, including: · New vaccine administration chapter · New recommendations regarding selection of storage units and temperature monitoring tools · New recommendations for vaccine transport · Updated information on available influenza vaccine products · Use of Tdap in pregnancy · Use of Tdap in persons 65 years of age or older · Use of PCV13 and PPSV23 in adults with immunocompromising conditions · New licensure information for varicella-zoster immune globulin Contact bookstore@phf.org for more information. For more news and specials on immunization and vaccines visit the Pink Book's Facebook fan page |
| covid vaccine studies 2023: Population Health Science Katherine M. Keyes, Sandro Galea, 2016-07-07 POPULATION HEALTH SCIENCE formalizes an emerging discipline at the crossroads of social and medical sciences, demography, and economics--an emerging approach to population studies that represents a seismic shift in how traditional health sciences measure and observe health events. Bringing together theories and methods from diverse fields, this text provides grounding in the factors that shape population health. The overall approach is one of consequentialist science: designing creative studies that identify causal factors in health with multidisciplinary rigor. Distilled into nine foundational principles, this book guides readers through population science studies that strategically incorporate: · macrosocial factors · multilevel, lifecourse, and systems theories · prevention science fundamentals · return on investment · equity and efficiency Harnessing the power of scientific inquiry and codifying the knowledge base for a burgeoning field, POPULATION HEALTH SCIENCE arms readers with tools to shift the curve of population health. |
| covid vaccine studies 2023: Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis Renato Alberto Sinico, Loïc Guillevin, 2019-09-13 This volume, written by well-known experts in the field, covers all aspects of Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV). The expression refers to a group of diseases, characterized by destruction and inflammation of small vessels. The clinical signs vary and affect several organs, such as the kidney, lung, skin, nervous system and others. The opening chapters give some historical hints, explain the genetic basis of the disease and provide insights into the pathogenesis derived from recent experimental studies and guides the reader through classification and nomenclature. A large part of the book is then devoted to a detailed description of the specific related diseases and their clinical presentations, the disease course, and potential complications. The advice regarding treatment is based on the best currently available evidence in this constantly evolving area. The book is part of Springer’s series Rare Diseases of the Immune System, which presents recently acquired knowledge on pathogenesis, diagnosis, and therapy with the aim of promoting a more holistic approach to these conditions. AAVs are systemic autoimmune diseases of unknown cause that affect small (to medium) sized blood vessels. They include granulomatosis with polyangiitis (formerly Wegener's granulomatosis), microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis (formerly Churg–Strauss syndrome). This volume will be an invaluable source of up-to-date information for all practitioners involved in the care of patients with these diseases. |
| covid vaccine studies 2023: Mucosal Vaccines Hiroshi Kiyono, 1996-10-23 This comprehensive, authoritative treatise covers all aspects of mucosal vaccines including their development, mechanisms of action, molecular/cellular aspects, and practical applications. The contributing authors and editors of this one-of-a-kind book are very well known in their respective fields. Mucosal Vaccines is organized in a unique format in which basic, clinical, and practical aspects of the mucosal immune system for vaccine development are described and discussed. This project is endorsed by the Society for Mucosal Immunology. - Provides the latest views on mucosal vaccines - Applies basic principles to the development of new vaccines - Links basic, clinical, and practical aspects of mucosal vaccines to different infectious diseases - Unique and user-friendly organization |
| covid vaccine studies 2023: Stuck Heidi J. Larson, 2020-07-01 Vaccine reluctance and refusal are no longer limited to the margins of society. Debates around vaccines' necessity -- along with quesitons around their side effects -- have gone mainstream, blending with geopolitical conflicts, political campaigns, celebrity causes, and natural lifestyles to win a growing number of hearts and minds. Today's anti-vaccine positions find audiences where they've never existed previously. Stuck examines how the issues surrounding vaccine hesitancy are, more than anything, about people feeling left out of the conversation. A new dialogue is long overdue, one that addresses the many types of vaccine hesitancy and the social factors that perpetuate them. To do this, Stuck provides a clear-eyed examination of the social vectors that transmit vaccine rumors, their manifestations around the globe, and how these individual threads are all connected. |
| covid vaccine studies 2023: Vaccines Paul A. Offit, Louis M. Bell, 2003-05-13 Get the straight facts about vaccines and make informed choices Do you wonder whether vaccines are safe and whether they are all really necessary? This completely revised and updated edition of the classic Vaccines: What You Should Know helps you sort through the latest information about vaccines in order to determine what is right for your family. Coauthored by Paul Offit, a member of the CDC advisory committee that determines which vaccines are recommended for use in the United States, this guide tells you what vaccines are made of and clearly explains how they are made, how they work, and the risks associated with them. This updated edition includes recommendations for the smallpox vaccine, the latest information on vaccines for travelers, and the latest on the progress of combination vaccines. Expanded information on vaccine safety includes discussion of vaccines and autism, mercury in vaccines, and the ability of children to tolerate numerous vaccines at once. |
| covid vaccine studies 2023: Canadian Immunization Guide Canada. Comité consultatif national de l'immunisation, Canada. National Advisory Committee on Immunization, 2006 The seventh edition of the Canadian Immunization Guide was developed by the National Advisory Committee on Immunization (NACI), with the support ofthe Immunization and Respiratory Infections Division, Public Health Agency of Canada, to provide updated information and recommendations on the use of vaccines in Canada. The Public Health Agency of Canada conducted a survey in 2004, which confi rmed that the Canadian Immunization Guide is a very useful and reliable resource of information on immunization. |
| covid vaccine studies 2023: Elderhood Louise Aronson, 2019-06-11 Finalist for the Pulitzer Prize in General Nonfiction A New York Times Bestseller Longlisted for the Andrew Carnegie Medal for Excellence in Nonfiction Winner of the WSU AOS Bonner Book Award Winner of the 2022 At Home With Growing Older Impact Award As revelatory as Atul Gawande's Being Mortal, physician and award-winning author Louise Aronson's Elderhood is an essential, empathetic look at a vital but often disparaged stage of life. For more than 5,000 years, old has been defined as beginning between the ages of 60 and 70. That means most people alive today will spend more years in elderhood than in childhood, and many will be elders for 40 years or more. Yet at the very moment that humans are living longer than ever before, we've made old age into a disease, a condition to be dreaded, denigrated, neglected, and denied. Reminiscent of Oliver Sacks, noted Harvard-trained geriatrician Louise Aronson uses stories from her quarter century of caring for patients, and draws from history, science, literature, popular culture, and her own life to weave a vision of old age that's neither nightmare nor utopian fantasy--a vision full of joy, wonder, frustration, outrage, and hope about aging, medicine, and humanity itself. Elderhood is for anyone who is, in the author's own words, an aging, i.e., still-breathing human being. |
| covid vaccine studies 2023: Vax-Unvax Robert F. Kennedy Jr., Brian Hooker, 2023-08-29 The Studies the CDC Refuses to Do This book is based on over one hundred studies in the peer-reviewed literature that consider vaccinated versus unvaccinated populations. Each study is analyzed, and health differences among infants, children, and adults who have been vaccinated and those who have not are presented and put in context. Readers will find information on: The infant/child vaccination schedule Thimerosal in vaccines Live virus vaccines The human papillomavirus (HPV) vaccine Vaccination and Gulf War illness Influenza (flu) vaccines Hepatitis B vaccination The COVID-19 vaccine Vaccines during pregnancy Given the massive push to vaccinate the entire global population, this book is timely and necessary for individuals to make informed choices for themselves and their families. |
| covid vaccine studies 2023: Design and Analysis of Vaccine Studies M. Elizabeth Halloran, Ira M. Longini, Jr., Claudio J. Struchiner, 2009-10-27 As well as being a reference for the design, analysis, and interpretation of vaccine studies, the text covers all design and analysis stages, from vaccine development to post-licensure surveillance, presenting likelihood, frequentists, and Bayesian approaches. |
| covid vaccine studies 2023: Adverse Effects of Vaccines Institute of Medicine, Board on Population Health and Public Health Practice, Committee to Review Adverse Effects of Vaccines, 2012-04-26 In 1900, for every 1,000 babies born in the United States, 100 would die before their first birthday, often due to infectious diseases. Today, vaccines exist for many viral and bacterial diseases. The National Childhood Vaccine Injury Act, passed in 1986, was intended to bolster vaccine research and development through the federal coordination of vaccine initiatives and to provide relief to vaccine manufacturers facing financial burdens. The legislation also intended to address concerns about the safety of vaccines by instituting a compensation program, setting up a passive surveillance system for vaccine adverse events, and by providing information to consumers. A key component of the legislation required the U.S. Department of Health and Human Services to collaborate with the Institute of Medicine to assess concerns about the safety of vaccines and potential adverse events, especially in children. Adverse Effects of Vaccines reviews the epidemiological, clinical, and biological evidence regarding adverse health events associated with specific vaccines covered by the National Vaccine Injury Compensation Program (VICP), including the varicella zoster vaccine, influenza vaccines, the hepatitis B vaccine, and the human papillomavirus vaccine, among others. For each possible adverse event, the report reviews peer-reviewed primary studies, summarizes their findings, and evaluates the epidemiological, clinical, and biological evidence. It finds that while no vaccine is 100 percent safe, very few adverse events are shown to be caused by vaccines. In addition, the evidence shows that vaccines do not cause several conditions. For example, the MMR vaccine is not associated with autism or childhood diabetes. Also, the DTaP vaccine is not associated with diabetes and the influenza vaccine given as a shot does not exacerbate asthma. Adverse Effects of Vaccines will be of special interest to the National Vaccine Program Office, the VICP, the Centers for Disease Control and Prevention, vaccine safety researchers and manufacturers, parents, caregivers, and health professionals in the private and public sectors. |
| covid vaccine studies 2023: Revelation , 1999-01-01 The final book of the Bible, Revelation prophesies the ultimate judgement of mankind in a series of allegorical visions, grisly images and numerological predictions. According to these, empires will fall, the Beast will be destroyed and Christ will rule a new Jerusalem. With an introduction by Will Self. |
| covid vaccine studies 2023: Gordis Epidemiology David D Celentano, Moyses Szklo, 2018-10-19 From the Department of Epidemiology at Johns Hopkins University and continuing in the tradition of award-winning educator and epidemiologist Dr. Leon Gordis, comes the fully revised 6th Edition of Gordis Epidemiology. This bestselling text provides a solid introduction to basic epidemiologic principles as well as practical applications in public health and clinical practice, highlighted by real-world examples throughout. New coverage includes expanded information on genetic epidemiology, epidemiology and public policy, and ethical and professional issues in epidemiology, providing a strong basis for understanding the role and importance of epidemiology in today's data-driven society. - Covers the basic principles and concepts of epidemiology in a clear, uniquely memorable way, using a wealth of full-color figures, graphs, charts, and cartoons to help you understand and retain key information. - Reflects how epidemiology is practiced today, with a new chapter organization progressing from observation and developing hypotheses to data collection and analyses. - Features new end-of-chapter questions for quick self-assessment, and a glossary of genetic terminology. - Provides more than 200 additional multiple-choice epidemiology self-assessment questions online. - Evolve Instructor Resources, including a downloadable image and test bank, are available to instructors through their Elsevier sales rep or via request at: https://evolve.elsevier.com |
| covid vaccine studies 2023: CPT Professional 2022 American Medical Association, 2021-09-17 CPT(R) 2022 Professional Edition is the definitive AMA-authored resource to help healthcare professionals correctly report and bill medical procedures and services. |
| covid vaccine studies 2023: Vaccines against RNA Viruses Juan Carlos Saiz, 2020-12-28 RNA viruses cause animal, human, and zoonotic diseases that affect millions of individuals, as is being exemplified by the devastating ongoing epidemic of the recently identified SARS-Cov-2. For years vaccines have had an enormous impact on overcoming the global burden of diseases. Nowadays, a vast number of different approaches, from purified inactivated and live attenuated viruses, nucleic acid (DNA or RNA) based candidates, virus-like particles, subunit elements, and recombinant viruses are been employed to combat viruses. However, for many of them efficient vaccines are not yet available. This will probably change dramatically with the current Covid-19 pandemic, as a vast variety of vaccinology approaches are being tested against it, with hundreds of candidates under development, dozens of them already in clinical trials, a fact that is breaking records in vaccine development and implementation. This is becoming possible thanks to the enormous work carried out during years to have the bases for a quick response, even against unknown pathogens, in an impressive short time. Here, results obtained with different vaccine´s methodological approaches against human (HIV, HCV, HRV) animal (PRRSV, PEDV, FMDV, VHSV) and zoonotic (RVF, WNV), RNA viruses are presented by field experts. |
| covid vaccine studies 2023: High-Octane Brain Michelle Braun, 2020-10-20 From a Harvard- and Yale-trained neuropsychologist, a science-backed five-step program to boost memory and dramatically decrease the risk of Alzheimer’s. American adults fear Alzheimer’s more than any other disease—including cancer—and because many don’t realize there is no genetic cause for 99 percent of Alzheimer’s cases, they don’t take the necessary steps to change lifestyle factors shown to significantly protect against the disease. In this book, board-certified neuropsychologist Dr. Michelle Braun inspires you to make lasting improvements by explaining the truth about brain health and providing expert guidance through the maze of conflicting media advice on supplements, brain games, nutrition, and exercise. Braun interviews eight leading brain health experts, combining their insights with cutting-edge research to offer proven strategies to implement the five steps of the High-Octane Brain. Interactive exercises help you develop a personalized program for optimal brain health. Dr. Braun also provides a tracking system with a visual depiction of progress, and shows the High-Octane Brain plan in action through the lives of clients. Packed with valuable tips you can implement immediately to minimize common “brain blips,” exercises to boost your memory within minutes, and inspiring insights from nine High-Octane Brain role models ages 44 to 103, this groundbreaking book helps put the future of your brain in your control. “Thorough, backed up by the best available research, and accessible.” —Barry Gordon, M.D., Ph.D., Director, Cognitive Neurology/Neuropsychology Division, Department of Neurology, Johns Hopkins Medical Institutions and University |
| covid vaccine studies 2023: The Belmont Report United States. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1978 |
| covid vaccine studies 2023: Contemporary Perspectives on Ageism Liat Ayalon, Clemens Tesch-Römer, 2018-05-22 This open access book provides a comprehensive perspective on the concept of ageism, its origins, the manifestation and consequences of ageism, as well as ways to respond to and research ageism. The book represents a collaborative effort of researchers from over 20 countries and a variety of disciplines, including, psychology, sociology, gerontology, geriatrics, pharmacology, law, geography, design, engineering, policy and media studies. The contributors have collaborated to produce a truly stimulating and educating book on ageism which brings a clear overview of the state of the art in the field. The book serves as a catalyst to generate research, policy and public interest in the field of ageism and to reconstruct the image of old age and will be of interest to researchers and students in gerontology and geriatrics. |
| covid vaccine studies 2023: Red Book Larry K. Pickering, American Academy of Pediatrics. Committee on Infectious Diseases, 2012 Developed by the AAP (American Academy of Pediatrics) Committee on Infectious Diseases in conjunction with the CDC (Centers for disease control), the FDA (Food and drug administration), and other leading institutions with contributions from hundreds of physicians nationwide, the newly revised and updated 2012 Red Book continues the tradition of excellence with the latest findings and clinical recommendations on the manifestations, etiology, epidemiology, diagnosis, and treatment of more than 200 childhood conditions. [Ed.]. |
| covid vaccine studies 2023: Immunization Safety Review Institute of Medicine, Board on Health Promotion and Disease Prevention, Immunization Safety Review Committee, 2004-09-30 This eighth and final report of the Immunization Safety Review Committee examines the hypothesis that vaccines, specifically the measles-mumps-rubella (MMR) vaccine and thimerosal-containing vaccines, are causally associated with autism. The committee reviewed the extant published and unpublished epidemiological studies regarding causality and studies of potential biologic mechanisms by which these immunizations might cause autism. Immunization Safety Review: Vaccines and Autism finds that the body of epidemiological evidence favors rejection of a causal relationship between thimerosal-containing vaccines and autism. The book further finds that potential biological mechanisms for vaccine-induced autism that have been generated to date are only theoretical. It recommends a public health response that fully supports an array of vaccine safety activities and recommends that available funding for autism research be channeled to the most promising areas. The book makes additional recommendations regarding surveillance and epidemiological research, clinical studies, and communication related to these vaccine safety concerns. |
| covid vaccine studies 2023: Trained Immunity-based Vaccines Jose Luis Subiza, Silvia Sánchez-Ramón, Oscar Palomares, Isabella Quinti, 2021-08-25 Dr. Jose Luis Subiza is the founder and CEO of Inmunotek SL. The other Topic Editors declare no competing interests with regard to the Research Topic subject. |
| covid vaccine studies 2023: CDC Yellow Book 2020 Centers for Disease Control and Prevention (CDC), 2019 The definitive reference for travel medicine, updated for 2020 A beloved travel must-have for the intrepid wanderer. -Publishers Weekly A truly excellent and comprehensive resource. -Journal of Hospital Infection The CDC Yellow Book offers everything travelers and healthcare providers need to know for safe and healthy travel abroad. This 2020 edition includes: � Country-specific risk guidelines for yellow fever and malaria, including expert recommendations and 26 detailed, country-level maps � Detailed maps showing distribution of travel-related illnesses, including dengue, Japanese encephalitis, meningococcal meningitis, and schistosomiasis � Guidelines for self-treating common travel conditions, including altitude illness, jet lag, motion sickness, and travelers' diarrhea � Expert guidance on food and drink precautions to avoid illness, plus water-disinfection techniques for travel to remote destinations � Specialized guidelines for non-leisure travelers, study abroad, work-related travel, and travel to mass gatherings � Advice on medical tourism, complementary and integrative health approaches, and counterfeit drugs � Updated guidance for pre-travel consultations � Advice for obtaining healthcare abroad, including guidance on different types of travel insurance � Health insights around 15 popular tourist destinations and itineraries � Recommendations for traveling with infants and children � Advising travelers with specific needs, including those with chronic medical conditions or weakened immune systems, health care workers, humanitarian aid workers, long-term travelers and expatriates, and last-minute travelers � Considerations for newly arrived adoptees, immigrants, and refugees Long the most trusted book of its kind, the CDC Yellow Book is an essential resource in an ever-changing field -- and an ever-changing world. |
| covid vaccine studies 2023: Overkill Paul A. Offit, 2020-04-14 A look at fifteen popular medical treatments that have been shown to be far more harmful than helpful, yet are still recommended by doctors. Modern medicine has made major advances in the last few decades, as more informed practices, thorough research, and incredible breakthroughs have made it possible to successfully treat and even eradicate many serious ailments. But we still rely on medical interventions that are vastly out of date and can adversely affect our health. In Overkill, Dr. Paul a Offit debunks fifteen common medical interventions that continue despite mounting evidence they are damaging or even deadly. Discussing everything from vitamins, sunscreen, and eyedrops for pinkeye to more serious procedures like heart stent placement and knee surgery, Offit—an acclaimed medical expert and patient advocate—tears down prolific medical propaganda that, for decades, has been causing more harm than good. Analyzing the history of how these practices came to be, the biology of what makes them so ineffective, and the medical culture that has consistently turned a blind eye, Overkill seeks to move the needle far away from these counterproductive treatments—and help patients advocate for their health. By educating ourselves, we can ask better questions and bring a much-needed skepticism to some of the drugs and surgeries that are too readily available—and too heavily promoted. |
| covid vaccine studies 2023: Vaccine Nation Elena Conis, 2015 While vaccination rates have soared and cases of preventable infections have plummeted, an increasingly vocal cross section of Americans have questioned the safety and necessity of vaccines. In Vaccine Nation, Elena Conis explores this complicated history and its consequences for personal and public health. |
| covid vaccine studies 2023: Gareth and Lynette Lancelot and Elaine the Passing of Arthur Houghton Mifflin Company, 2019-03-16 This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work. This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work. As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant. |
| covid vaccine studies 2023: Coronaviruses Helena J. Maier, Erica Bickerton, 2021-09-08 This detailed new edition provides a comprehensive collection of protocols applicable to all members of the Coronavirinae sub-family currently and that are also transferrable to other fields of virology. Beginning with a section on detection, discovery, and evolution, the volume continues with coverage of propagation and titration of coronaviruses, genome manipulation, study of virus-host interactions, as well as imaging coronavirus infections. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Coronaviruses: Methods and Protocols, Second Edition serves as a valuable guide to researchers working to identify and control viruses with increased potential to cross the species barrier and to develop the diagnostics, vaccines, and antiviral therapeutics that are required to manage future outbreaks in both humans and animals. |
| covid vaccine studies 2023: Advances in DNA Vaccines Maria Isaguliants, Karl Ljungberg, 2021 DNA is a rapidly developing vaccine platform for cancer and infectious and non-infectious diseases. Plasmids are used as immunogens to encode proteins to be further synthesized in vaccine recipients. DNA is mainly synthetic, ensuring enhanced expression in the cells of vaccine recipients (mostly mammalians). Their introduction into the host induces antibody and cellular responses. The latter are often more pronounced, and mimic the events occurring in infection, especially viral. There are a few distinct ways in which the vaccine antigen can be processed and presented, which determine the resulting immune response and which can be manipulated. Routinely, the antigen synthesized within the host cell is processed by proteasome, loaded onto, and presented in a complex with MHC I molecules. Processing can be re-routed to the lysosome, or immunogen can be secreted for further presentation in a complex with MHC II. Apart from expression, vaccination efficacy depends on DNA delivery. DNA immunogens are generally administered by intramuscular or intradermal injections, usually followed by electroporation, which enhances delivery 1000-fold. Other techniques are also used, such as noninvasive introduction by biojectors, skin applications with plasters and microneedles/chips, sonication, magnetofection, and even tattooing. An intense debate regarding the pros and cons of different routes of delivery is ongoing. A number of studies have compared the effect of delivery methods at the level of immunogen expression, and the magnitude and specificity of the resulting immune response. According to some, the delivery route determines immunogenic performance; according to others, it can modulate the level of response, but not its specificity or polarity. The progress of research aiming at the optimization of DNA vaccine design, delivery, and immunogenic performance has led to a marked increase in their efficacy in large species and humans. New DNA vaccines for use in the treatment of infectious diseases, cancer, allergies, and autoimmunity are forthcoming. This Special Issue covers various aspects of DNA vaccine development. |
| covid vaccine studies 2023: Deadliest Enemy Michael T. Osterholm, Mark Olshaker, 2020 Infectious disease has the terrifying power to disrupt everyday life on a global scale, overwhelming public and private resources and bringing trade and transportation to a halt. In today's world, it's easier than ever to move people, animals, and materials around the planet, but the same advances that make modern infrastructure so efficient have made epidemics and even pandemics nearly inevitable. So what can -- and must -- we do in order to protect ourselves? Drawing on the latest medical science, case studies, and policy research, Deadliest enemy explores the resources and programs we need to develop if we are to keep ourselves safe from infectious disease.-- |
| covid vaccine studies 2023: Eating and Activity Guidelines for New Zealand Adults New Zealand. Ministry of Health, Louise McIntyre, Anna Jackson, Harriette Carr, Mary-Ann Carter, Sally Mackay, Sarah Gerritsen, 2020 These Guidelines provide the current evidence-based recommendations on healthy eating and physical activity for New Zealand adults, including pregnant and breastfeeding women. ... focus on the detail practitioners need at a glance: that is, what people need to eat or do, a summary of the rationale - 'why' - and a little on how to put the recommendations into practice--Page iv. |
| covid vaccine studies 2023: Research Methods and Design Beyond a Single Discipline Heting Chu, 2024-04-01 Research Methods and Design Beyond a Single Discipline presents and discusses 15 research methods after an overview of each, an illustration of the research process, and an examination of related topics. The focus of this book is on data collection techniques (e.g., interviewing, observation, questionnaires) and research design. Research methods are named and categorized by data collection techniques in this book rather than by the quantitative and qualitative dichotomy used for data analysis techniques. Each of the 15 research methods included in the book is depicted regarding its functions, features, applications, and dos and don’ts, with examples and case studies from various disciplines. Research methodology development in research design starts with selection of data collection techniques, which takes into consideration research questions of a study and research method features. Data analysis techniques and selection are described as part of the research methodology development to help readers choose the most appropriate methodology for their own research, and put research design into practice. This book is essential for masters and doctoral students, and researchers who wish to learn about research methods and design comprehensively and systematically, as well as instructors delivering research methods courses across the social and behavioral sciences. |
| covid vaccine studies 2023: Guidance on development and implementation of a national deployment and vaccination plan for vaccines against pandemic influenza and other respiratory viruses of pandemic potential World Health Organization, 2023-12-11 Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at all levels – local, regional and global. The World Health Organization (WHO) and its partners have prepared this revised guidance document to assist countries update their national deployment and vaccination plans (NDVPs) by leveraging global learnings from past pandemic responses, including the recent COVID-19 vaccination effort. The development and testing of a NDVP would not only advance pandemic preparedness efforts but would also have benefits in terms of increasing national capabilities to manage other health emergencies which require emergency vaccination campaigns. |
| covid vaccine studies 2023: Advanced Vaccination Technologies for Infectious and Chronic Diseases Vasso Apostolopoulos, Lalitkumar K. Vora, Vivek P. Chavda, 2024-03-25 The role of vaccines is emerging and even critical to ending infectious and chronic diseases and pandemics alike. The design and development of new vaccines could lead to improved health. Handbook on Advanced Vaccination Technologies for Infectious and Chronic Disease discusses these new developments and introduces the reader to the current state of the science and the outlook going forward from the discovery of vaccines to the clinical trials of personalized vaccines. Handbook on Advanced Vaccination Technologies for Infectious and Chronic Diseases is a valuable reference for occupational health professionals whose role involves supervision of immunization programs such as those working in the National Health Service, some sectors of higher education and the pharmaceutical industry. - Offers comprehensive coverage of different vaccine platforms and their development - Includes information on the regulatory perspective of vaccine development - Describes different delivery approaches for vaccinology - Explains the clinical development of vaccines along with novel platforms - Covers all recent developments of vaccine production technologies, new types of vaccines, and ongoing research that could prevent future pandemics |
| covid vaccine studies 2023: Vaccines and Immunization Services During the Pandemic Era and Beyond Edina Amponsah-Dacosta, Oghenebrume Wariri, Anthony Afum-Adjei Awuah, Alma Fulurija, 2024-03-28 |
| covid vaccine studies 2023: Playing God Nick Spencer, Hannah Waite, 2024-03-21 Could science one day 'defeat death'? What would alien contact mean for humanity? Has medicine finally found a cure for sadness? Will AI replace us? For too long, the 'science and religion' debate has fixated on creation, evolution, cosmology, miracles and quantum theory. But this, argue Nick Spencer and Hannah Waite, is a mistake. Religious belief has survived, and thrived, under many different models of the universe. It was never intended to be a competing explanation for the science of any age. Where science and religion really do come together - sometimes furiously, sometimes fruitfully - is over the status and nature of the human. And that has never been more important than today. Whether it's the quest for immortality or the search for alien life, the treatment of pandemics or 'animal personhood', AI or mental health, abortion or genetic editing, science is making advances that are posing huge questions about what it means to be human, whether we should change ourselves, and how far we should 'play God'. These developments are only going to grow in significance. Playing God brings readers up to date with the latest developments but also draws out their moral and religious dimensions. In so doing, it shows how the future of science and religion is inextricably tied up with the future of humanity. |
| covid vaccine studies 2023: Pandemic Fissures Suddhabrata Deb Roy, 2024-08-09 This book analyses India’s response to COVID-19, using an intersectional framework that highlights the roles of the central government, regional governments, and community organisations, both formal and informal. The volume brings forward the immense potential embedded within collective communitarian formations by exploring themes such as disaster capitalism, municipal socialism, civic capitalism, apocalypse or disaster communism, and Marxist humanism in relation to the management strategies exhibited by the Indian government towards the COVID-19 pandemic. It underscores the necessity for imagining a scenario where egalitarian and socially just policies replace the dominance of capitalism. Part of the Academics, Politics and Society in the Post-COVID World series, the book will be an essential read for scholars and researchers of sociology, political studies, cultural studies, social anthropology, South Asia studies, pandemic studies, and postcolonial studies. |
| covid vaccine studies 2023: Clinical Trials Steven Piantadosi, 2024-04-03 Clinical Trials Comprehensive resource presenting methods essential in planning, designing, conducting, analyzing, and interpreting clinical trials The Fourth Edition of Clinical Trials builds on the text’s reputation as a straightforward, detailed, and authoritative presentation of quantitative methods for clinical trials, discussing principles of design for various types of clinical trials and elements of planning the experiment, assembling a study cohort, assessing data, and reporting results. Each chapter contains an introduction and summary to reinforce key points. Discussion questions stimulate critical thinking and help readers understand how they can apply their newfound knowledge. Written by a highly qualified author with significant experience in the field, the Fourth Edition of Clinical Trials approaches the topic with: Problems that may arise during a trial, and accompanying common sense solutions Design alternatives for addressing many questions in therapeutic development Statistical principles with new and provocative topics, such as generalizing results, operating characteristics, trial issues during the COVID-19 pandemic, and more Alternative medicine, ethics, middle development, comparative studies, adaptive designs, and clinical trials using point of care data Revamped exercise sets, updated and extensive references, new material on endpoints and the developmental pipeline, and revisions of numerous sections, tables, and figures Standing out due to its accessible and broad coverage of statistical design methods which are the building blocks of clinical trials and medical research, Clinical Trials is an essential learning aid on the subject for undergraduate and graduate clinical trials courses. |
Coronavirus - World Health Organization (WHO)
May 27, 2025 · Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with the virus will …
Coronavirus disease (COVID-19)
Aug 9, 2023 · Key facts COVID-19 is a disease caused by a virus. The most common symptoms are fever, chills, and sore throat, but there are a …
Coronavirus disease (COVID-19) – World Health Organization
Information on COVID-19, the infectious disease caused by the most recently discovered coronavirus.
Coronavirus disease (COVID-19)
Mar 28, 2023 · COVID-19 is the disease caused by a coronavirus called SARS-CoV-2. WHO first learned of this new virus on 31 December 2019, …
مرض فيروس كورونا (كوفيد-19)
تواصل منظمة الصحة العالمية رصد هذه الجائحة والاستجابة لها. وستُحدّث هذه الصفحة المخصصة للأسئلة والأجوبة كلما زادت المعارف بشأن …
Results of Phase III Study of Booster Vaccination of Kostaive™, …
December 21, 2023 . ... COVID-19 vaccine as a booster dose in adults who have previously received an mRNA vaccine. We show that a 5booster dose of ARµg CT-154 is safe, is ... (in …
Immunization Recommendations for the 2023-2024 …
Syndrome (GBS) after inactivated influenza vaccine. Some . studies have observed a higher risk for GBS after influenza . infection than vaccination. COVID-19. What products are available? …
WHO SAGE roadmap on uses of COVID-19 vaccines in the …
Mar 30, 2023 · The COVID- 19 situation in early 2023, more than three years after the start of the pandemic, has changed significantly. ... studies was taken into account, as well as lessons …
The role of COVID-19 vaccines in preventing post-COVID-19 …
Jan 24, 2024 · Objective To study the association between COVID-19 vaccination and the risk of post-COVID-19 cardiac and thromboembolic complications. Methods We conducted a …
August 23, 2021 Approval Letter - Comirnaty - U.S. Food and …
Aug 23, 2021 · COVID-19 Vaccine, mRNA. ... We are deferring submission of your pediatric studies for ages younger than 16 years ... Final Report Submission: October 31, 2023 . 2. …
Intellectual Property (IP) and Technology Transfer for COVID …
concerns regarding equitable access during the COVID-19 pandemic. 3 This study endeavors to shed light on this question in the context of the COVID-19 pandemic. b. Multiple factors …
Addressing confounding in studies of vaccine effectiveness
WHO Global Consultation for Vaccine Effectiveness Studies 14 September, 2023. ... Less likely to receive vaccine Possibly higher risk of infection, but possibly lower likelihood of ... Suggests …
Post-Vaccination Syndrome: A Descriptive Analysis of …
Nov 9, 2023 · [Pfizer-BioNTech] vaccine, and 86 (37%) received the mRNA-1273 [Moderna] vaccine. The median time from the day of index vaccination to symptom onset was three days …
Pfizer-BioNTech COVID-19 Vaccine, MONOVALENT
Pfizer-BioNTech COVID-19 Vaccine, MONOVALENT [ MAROON cap with MAROON Label Border] ... 2022, this formulation is not used in DAIT studies) 2.1. Vaccine Storage Prior to Use …
Spikevax (COVID-19 Vaccine, mRNA) - U.S. Food and Drug …
Spikevax (COVID-19 Vaccine, mRNA) What data did FDA evaluate to support the September 11, 2023, approval of the following: • a single dose for individuals 12 through 17 years of age • a …
SARS-CoV-2 Vaccine Breakthrough Surveillance Resource
The criteria for a vaccine breakthrough case requires a positive lab test (either a PCR test or antigen test) occurring at least 14 days after a person received their last recommended dose of …
Report to the Committee on Armed Services of - Health.mil
Sep 29, 2023 · Following the COVID Vaccine Requirement September 2023 The estimated cost of this report or study for the Department of Defense is approximately $29,000 in Fiscal Years …
Effectiveness of the Coronavirus Disease 2019 (COVID-19) …
Dec 17, 2022 · The purpose of this study was to evaluate whether a bivalent COVID-19 vaccine protects against COVID-19. Methods. Employees of Cleveland Clinic in employment on the day …
Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 …
4 . on June 13, 2024, requested authorization of their COVID-19 vaccine to include a monovalent JN.1-based 2024-2025 Formula. The clinical effectiveness data accrued with the Novavax …
Interim recommendations for the use of mRNA COVID-19 …
Jul 19, 2023 · and target populations for booster doses are derived from the revised March 2023 WHO prioritization roadmap ... Pfizer/BioNTech mRNA COVID -19 vaccine: For individuals …
Views on COVID-19 vaccination among residents of Eldoret, …
cally black and segregated areas were of lesser quality and value (Cho et al., 2023). Similarly, some studies in Kenya have attributed vaccine hesitancy to deep-seated mistrust in vaccine …
Recommendation for the 2023-2024 Formula of COVID-19 …
Jan 26, 2023 · suggests that a monovalent XBB-lineage vaccine is warranted for the 2023–2024 update. The VRBPAC met on June 15, 2023, to discuss the strain composition for the 2023-2024
FACT SHEET FOR HEALTHCARE PROVIDERS ADMINISTERING …
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the emergency use of Moderna COVID-19 Vaccine (2024-2025 Formula) for active
Evidence Review of the Adverse - The National Academies Press
revoked on June 1, 2023; therefore, only a small number of studies were available for examination. NVX-CoV2373 (Novavax) was the last available vaccine in the United States, and …
CPT® Category I New Immunization* Vaccine Codes …
3 days ago · Influenza virus vaccine, H5N1, derived from cell cultures, adjuvanted, for intramuscular use April 1, 2025 July 1, 2025 CPT® 2026 # ⚫90612 Influenza virus vaccine, …
FACT SHEET FOR HEALTHCARE PROVIDERS ADMINISTERING …
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the emergency use of Moderna COVID-19 Vaccine (2024-2025 Formula) for active
Alaska Influenza and COVID-19 Surveillance Summary, 2023 …
Oct 16, 2024 · Vaccine Coverage . Influenza immunization coverage for the 2023–24 season based on VacTrAK data was 23.7% among Alaskans aged 18 years and older, similar to the …
Assessing COVID-19 vaccine effectiveness in observational …
methods under a variety of scenarios. The methods are used to estimate vaccine effectiveness against COVID-19 outcomes using observational data on over 120,000 residents of Abruzzo, …
Strategic and scientific contributions of human challenge trials …
typhoid conjugate vaccines, RTS,S malaria vaccine, and the MVA85A BCG-booster vaccine candidate all showed similar VE in adult human challenge vaccine trials compared with …
Emergency Use Authorization for Vaccines to Prevent …
Contains Nonbinding Recommendations . Emergency Use Authorization for Vaccines to Prevent COVID-19 Guidance for Industry . This guidance is intended to remain in effect until November …
2024–2025 COVID-19 Vaccination Guidance - Centers for …
Any number of previous doses of any COVID-19 vaccine, NOT. including 1 dose of any 2024–25 COVID-19 vaccine Give 1 dose at least 8 weeks after the last dose, followed by 1 dose 6 …
COVID-19 vaccine effectiveness against SARI among …
This document reports the pooled estimates from the ECDC test -negative case–control study of COVID-19 vaccine effectiveness against hospitalisation with SARS -CoV-2, conducted through …
Discrepancies in the portrayal of the COVID-19 vaccine in …
Nov 8, 2023 · Accepted 4 April 2023 KEYWORDS The COVID-19 vaccine; news values; Chinese and US international media; corpus-based discourse analysis; discursive news values ... The …
Recommendations: High-risk Spring 2023 COVID-19 Vaccine …
Recommendations: High-risk Spring 2023 COVID-19 Vaccine Booster Dose Program in Ontario 4 Implementation considerations related to additional doses The majority of the population in …
COVID-19 Declination Form 2023-2024 - Providence Residency
COVID-19 Declination Form 2023-2024 • COVID-19 can be very contagious and spreads quickly. ... • I cannot get COVID-19 from the vaccine and studies show that people who have antibodies …
Stroke After SARS-CoV-2 mRNA Vaccine: A Nationwide …
Ihle-Hansen et al Stroke After SARS-CoV-2 mRNA Vaccine Stroke. 2023;54:e190–e193. DOI: 10.1161/STROKEAHA.122.040430 May 2023 e191 ... tion studies from France, the United …
Individuals using assistive technology may not be able to fully …
14.5 Booster Dose With Pfizer-BioNTech COVID-19 Vaccine, Bivalent ... An overview of clinical studies contributing to the safety assessment of COMIRNATY is provided in Table 1.
COVID-19 Vaccines - cdc.gov
Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID -19 Vaccine Effectiveness Against Symptomatic SARS -CoV-2 Infectio n Attributable to Co-Circulating Omicron Variants …
Update on Global COVID-19 vaccination - World Health …
5 January 2023 Update on Global COVID-19 ... 13.1 Billion doses of COVID-19 vaccine have been administered globally DATA AS OF JANUARY 03. Out of 194 WHO Member States. have . …
Individuals using assistive technology may not be able to fully …
Jun 5, 2024 · Individuals using assistive technology may not be able to fully access the information contained in this file. For assistance, please call 800-835-4709 or 240-402-8010, …
Frequently Asked Questions - Centers for Medicare
expected May 11, 2023, expiration of the federal PHE for COVID-19 or any associated unwinding plans. Further, any existing waivers currently in effect and authorized under section 1135 of the …
COVID-19 Declination Form 2023-2024 - Providence
COVID-19 Declination Form 2023-2024 • COVID-19 can be very contagious and spreads quickly. ... • I cannot get COVID-19 from the vaccine and studies show that people who have antibodies …
Emergency Use Instructions (EUI) Fact Sheet for Recipients …
The 2024-2025 Formula Moderna COVID-19 Vaccine is made in the same way as the Moderna COVID-19 Vaccine (original monovalent), Moderna COVID-19 vaccine (Bivalent), and Moderna …
Annex: Statement on the antigen composition of COVID-19 …
May 18, 2023 · Annex 1: Evidence to support considerations of an update to COVID-19 vaccine antigen composition ... are very limited in terms of the number of studies, vaccine products …
Core protocol for ECDC studies of COVID-19 vaccine …
Core protocol for ECDC VEBIS studies of COVID-19 vaccine effectiveness against hospitalisation with SARI, Ver 3.0 TECHNICAL REPORT 1 ... (SARS-CoV-2) causing coronavirus disease …
Effectiveness of COVID-19 vaccination against COVID-19 …
Few studies internationally have analysed COVID-19 vaccine effectiveness against COVID-19 death and all-cause mortality using death certification1 and docu-mented how this has …
Group Life COVID-19 Mortality Survey Report - Society of …
the COVID-19 pandemic, as compared to prior period baseline mortality results. COVID-19 is caused by the novel coronavirus SARS-CoV-2, which was identified in 2019. As of the writing …
December 14, 2023 - U.S. Food and Drug Administration
Dec 14, 2023 · U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov December 14, 2023 . Joseph A. Ladapo, MD, PhD . State Surgeon General
COVID-19, RSV, and Influenza for 2023-2024 Season
September 13, 2023 1200 (12:00 PM EDT) NH-HAN 202309131 . COVID-19, RSV, and Influenza for 2023-2024 Season . Key Points and Recommendations: • CDC’s Advisory Committee on …
The ups and downs of observational vaccine research - The …
generation smallpox vaccine licensed for prevention of mpox based on animal efficacy studies, and human safety and immunogenicity studies. 1,2. Although previous studies from Africa have …
Undervaccination and severe COVID-19 outcomes: meta …
observational epidemiological studies.8–15 For example, a study from Israel found vaccine effectiveness of 76% (95% CI 72–79) against COVID-19 hospitalisation and ... We searched …
Vaccines and Related Biological Products Advisory Committee …
January 26, 2023 . FDA Briefing Document ... Spikevax (COVID-19 Vaccine, mRNA) referred to as Moderna COVID -19 Vaccine under ... Multiple studies describe neutralizing antibody …
Information on COVID-19 Vaccine (2023-2024 Formulation)
2023-2024 COVID-19 Vaccine Booster FAQ 1 V3. Updated October 10, 2023 Information on COVID-19 Vaccine (2023-2024 Formulation) ... test (if infection was asymptomatic). Studies …
Emergency Use Instructions (EUI) Fact Sheet for Recipients …
The 2024-2025 Formula Moderna COVID-19 Vaccine is made in the same way as the Moderna COVID-19 Vaccine (original monovalent) , Moderna COVID -19 vaccine (Bivalent), and …
Circulating Spike Protein Detected in Postâ COVID-19 mRNA …
868 March 14, 2023 Circulation. 2023;147:867–876. DOI: 10.1161/CIRCULATIONAHA.122.061025 Yonker et al Circulating Spike in Post–COVID-19 Vaccine Myocarditis have been shown to …
